BioVersys and partners publish in the prestigious journal of Nature Communications pre-clinical development data of AlpE (alpibectir and ethionamide), an innovative drug combination that overcomes ...
Pembro, made by pharma giant MSD, is hailed as a drug that saves and prolongs lives but it comes at an exorbitant cost ...
How Merck keeps the price of its lifesaving cancer drug, Keytruda, sky-high, locking out patients and squeezing health care ...
Three years after voters approved funding for a new water storage tank at the Pleasant Valley Water Treatment Facility, the ...
I’m mostly a tech investor, but I like to keep some dividend holdings as well. For example, I’ve been a Vanguard Dividend ...
Dozens of bills in more than 15 states are targeting harmful additives, many of which have been ignored by the FDA ...
Charles R. Goulding and Andressa Bonafe spotlight a pivotal moment at Additive Manufacturing Strategies 2026, where Arvind ...
Instead, they were there to deliver legal threats from a care home operator for speaking out in a BBC documentary. Sheriff ...
Investing in small biotech companies that make sufficient progress in regulatory approval and commercialization can ...
Opinion
2dOpinion
Medicare is experimenting with having AI review claims – a cost-saving measure that could risk denying needed care
The impact of using AI to evaluate these prior authorizations is unclear. AI could allow tech companies to automatically approve more cases, which could speed up decisions. However, companies could ...
That raises the stakes for a second area of Moderna’s research. In a partnership with Merck, it’s been using its mRNA ...
April 10, 2026 / RedChip Companies will air interviews with BIO-key International, Inc. (Nasdaq:BKYI), 20/20 Biolabs, Inc.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results